The Redistribution® technology is a high content cell-based assay approach, which monitors the cellular translocation of GFP-tagged proteins in response to drug compounds or other stimuli. The technology offers several advantages for your high content screening programs, including:
- Better understanding of effects and responses in signal transduction pathways - study the complex effect of your compounds in a cellular environment
- Better hit selection early in the drug discovery process - acquire multiple readouts to indicate toxicity and morphological changes
- Increases speed of compound characterization and decreases reagent costs - Redistribution® assays can easily be multiplexed with Cellomics HCS Reagent Kits in a single assay
- Removes need for in-house assay development - select from a broad range of validated off-the-shelf assays
- Automation friendly - just plate cells, add test compounds and measure readout in a high content imager
Depending on your needs, we offer:
|
